This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Enrollment
70
Bilateral middle meningeal artery embolization using TRUFILL n-BCA liquid embolic system
Barrow Neurological Institute at St. Joseph's Hospital
Phoenix, Arizona, United States
NOT_YET_RECRUITINGJohn Muir Physician Network Clin. Research Center
Walnut Creek, California, United States
NOT_YET_RECRUITINGHartford Hospital
Change from baseline, in number of migraine days
Time frame: over 28 days
Change from baseline in migraine days frequency
Time frame: 3 months and 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hartford, Connecticut, United States
University of Buffalo Medical Center
Buffalo, New York, United States
NOT_YET_RECRUITINGMount Sinai
New York, New York, United States
RECRUITINGStony Brook University Medical Center
Stony Brook, New York, United States
RECRUITINGThomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
RECRUITINGSemmes Murphey Foundation
Memphis, Tennessee, United States
RECRUITINGWest Virginia University
Morgantown, West Virginia, United States
RECRUITING